A Bayesian network meta-analysis of the primary definitive therapies for locoregionally advanced nasopharyngeal carcinoma: IC+CCRT, CCRT+AC, and CCRT alone.
Zhan-Jie ZhangLiang-Liang ShiXiao-Hua HongBo-Ya XiaoGuo-He LinQuentin LiuBi-Cheng WangPublished in: PloS one (2022)
IC+CCRT could be recommended as a front-preferred primary definitive therapy for patients with LANPC.